ATE540691T1 - Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung - Google Patents

Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Info

Publication number
ATE540691T1
ATE540691T1 AT08153545T AT08153545T ATE540691T1 AT E540691 T1 ATE540691 T1 AT E540691T1 AT 08153545 T AT08153545 T AT 08153545T AT 08153545 T AT08153545 T AT 08153545T AT E540691 T1 ATE540691 T1 AT E540691T1
Authority
AT
Austria
Prior art keywords
vaccine formulation
parenteral administration
excipient
allergen
allergen composition
Prior art date
Application number
AT08153545T
Other languages
English (en)
Inventor
Eike Gunther Wuestenberg
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38093538&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE540691(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Application granted granted Critical
Publication of ATE540691T1 publication Critical patent/ATE540691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT08153545T 2007-03-28 2008-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung ATE540691T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90731707P 2007-03-28 2007-03-28
EP07105094A EP1974745B1 (de) 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen Impfstoffformulierung für subkutane Verabreichung

Publications (1)

Publication Number Publication Date
ATE540691T1 true ATE540691T1 (de) 2012-01-15

Family

ID=38093538

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07105094T ATE522228T1 (de) 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung
AT08153545T ATE540691T1 (de) 2007-03-28 2008-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für parenterale verabreichung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07105094T ATE522228T1 (de) 2007-03-28 2007-03-28 Verwendung einer hilfsstoffhaltigen impfstoffformulierung für subkutane verabreichung

Country Status (5)

Country Link
US (1) US20120141536A1 (de)
EP (1) EP1974745B1 (de)
AT (2) ATE522228T1 (de)
DK (2) DK1974745T3 (de)
ES (2) ES2370043T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012392291B2 (en) * 2012-10-19 2017-12-07 Hal Allergy Holding B.V. Compositions for immunotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US8491909B2 (en) * 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
JP2007524096A (ja) 2004-02-26 2007-08-23 アルカベロ アクチェセルスカプ 粘膜投与用ワクチンの治療可能性の評価方法
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration

Also Published As

Publication number Publication date
DK1974745T3 (da) 2011-11-28
EP1974745B1 (de) 2011-08-31
ATE522228T1 (de) 2011-09-15
US20120141536A1 (en) 2012-06-07
DK1974746T3 (da) 2012-04-10
ES2380172T3 (es) 2012-05-09
ES2370043T3 (es) 2011-12-12
EP1974745A1 (de) 2008-10-01

Similar Documents

Publication Publication Date Title
CY1122466T1 (el) Σκευασμα αντισωματος αντι il-17ra και θεραπευτικα σχηματα για την αγωγη της ψωριασης
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
CY1119433T1 (el) Αμινο-υποκατεστημενες ιμιδαζοπυριδαζινες
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
CO6670520A2 (es) Lactmas sustituidas con piperidinio como moduladores de gpr119
NI201300074A (es) Novedosos derivados de azabencimidazol cíclico útiles como agentes antidiabéticos.
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
ECSP10010216A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
BR112012027759A2 (pt) Conjugados de peptídeos de agonistas de receptores glp-1 e gastrina e seu uso
CU20120161A7 (es) 5-fluoro-1h-pirazolopiridinas sustituidas
BRPI1009637A2 (pt) composto, composição e uso de um composto
BR112014010590A2 (pt) 18-metil-6,7-metilen-3-oxo-17-pregn-4-eno-21,17?-carbolactonas, preparações farmacêuticas contendo os compostos mencionados e seu uso na terapia da endometriose
BR112015003109A2 (pt) Composto, composição, uso de um composto, e, métodos para tratar ou prevenir um distúrbio, condição ou doença e para tratar diabetes mellitus tipo 2.
BR112015012366A2 (pt) antagonistas de cxcr7
BR112014027117A2 (pt) derivados de pirazol aminopirimidina como moduladores de lrrk2 para uso no tratamento de doença de parkinson
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
BR112012027197A2 (pt) combinação ou composição farmacêutica, seu uso, kit, e compostos para tratamento de doenças oncológicas e fibróticas
ATE538100T1 (de) Aminotetrahydroindazoloessigsäuren
EA201171043A1 (ru) Композиции и способы длительной терапии с применением аминопиридинов
CR20110318A (es) Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos
SMT201500190B (it) Composizioni comprendenti un anticorpo a p2-specifico o un suo frammento per l'uso nel trattamento del diabete, intolleranza al glucosio o insulino-resistenza indotta dall'obesita'
CU20100111A7 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
BR112012031873A2 (pt) antagonistas de ciclo-hexil-azetidinila do ccr2
BR112012030482A2 (pt) tratamento de diabetes tipo 2
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof